Intestinal microbiota controls graft-versus-host disease independent of donor-host genetic disparity.

[1]  S. Carding,et al.  Extracellular vesicles produced by the human gut commensal bacterium Bacteroides thetaiotaomicron elicit anti-inflammatory responses from innate immune cells , 2022, Frontiers in Microbiology.

[2]  M. Koyama,et al.  Lithium attenuates graft-versus-host disease via effects on the intestinal stem cell niche. , 2022, Blood.

[3]  N. Ajami,et al.  Mucus-degrading Bacteroides link carbapenems to aggravated graft-versus-host disease , 2022, Cell.

[4]  Yanlin Zhou,et al.  Bacteroides thetaiotaomicron relieves colon inflammation by activating aryl hydrocarbon receptor and modulating CD4+T cell homeostasis. , 2020, International immunopharmacology.

[5]  S. Itzkovitz,et al.  Diet Diurnally Regulates Small Intestinal Microbiome-Epithelial-Immune Homeostasis and Enteritis , 2020, Cell.

[6]  S. Proll,et al.  Urethral microbiota in men: Association of Haemophilus influenzae and Mycoplasma penetrans with nongonococcal urethritis. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  Daigo Hashimoto,et al.  Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation. , 2020, The New England journal of medicine.

[8]  P. Hugenholtz,et al.  Continuous pre- and post-transplant exposure to a disease-associated gut microbiome promotes hyper-acute graft-versus-host disease in wild-type mice , 2020, Gut microbes.

[9]  A. Hart,et al.  Bacteroides thetaiotaomicron-derived outer membrane vesicles promote regulatory dendritic cell responses in health but not in inflammatory bowel disease , 2019, Microbiome.

[10]  Amanda J. Pickard,et al.  Lactose drives Enterococcus expansion to promote graft-versus-host disease , 2019, Science.

[11]  N. Waddell,et al.  MHC Class II Antigen Presentation by the Intestinal Epithelium Initiates Graft-versus-Host Disease and Is Influenced by the Microbiota. , 2019, Immunity.

[12]  G. Hill,et al.  The primacy of gastrointestinal tract antigen presenting cells in lethal graft-versus-host disease. , 2019, Blood.

[13]  D. Fredricks.  The gut microbiota and graft-versus-host disease. , 2019, The Journal of clinical investigation.

[14]  K. Clément,et al.  Comparative Evaluation of Microbiota Engraftment Following Fecal Microbiota Transfer in Mice Models: Age, Kinetic and Microbial Status Matter , 2019, Front. Microbiol..

[15]  George Grant,et al.  Bacteroides thetaiotaomicron Ameliorates Colon Inflammation in Preclinical Models of Crohn’s Disease , 2018, Inflammatory bowel diseases.

[16]  Oliver S. Thomas,et al.  Neutrophils provide cellular communication between ileum and mesenteric lymph nodes at graft-versus-host disease onset. , 2018, Blood.

[17]  Daniel J. Wilson,et al.  The harmonic mean p-value for combining dependent tests , 2019, Proceedings of the National Academy of Sciences.

[18]  B. Blazar,et al.  Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets. , 2017, The New England journal of medicine.

[19]  B. Blazar,et al.  Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy. , 2017, The New England journal of medicine.

[20]  Floor Hugenholtz,et al.  Mouse models for human intestinal microbiota research: a critical evaluation , 2017, Cellular and Molecular Life Sciences.

[21]  J. Colombel,et al.  Acute graft-versus-host disease of the gut: considerations for the gastroenterologist , 2017, Nature Reviews Gastroenterology & Hepatology.

[22]  P. Hari,et al.  Current Use and Trends in Hematopoietic Cell Transplantation in the United States. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[23]  A. Plantinga,et al.  Stool Microbiota at Neutrophil Recovery Is Predictive for Severe Acute Graft vs Host Disease After Hematopoietic Cell Transplantation , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  P. Hugenholtz,et al.  Acute graft-versus-host disease is regulated by an IL-17-sensitive microbiome. , 2017, Blood.

[25]  A. Ganser,et al.  Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel. , 2017, Blood.

[26]  Paul J. McMurdie,et al.  Exact sequence variants should replace operational taxonomic units in marker-gene data analysis , 2017, The ISME Journal.

[27]  Jan P. Meier-Kolthoff,et al.  The Mouse Intestinal Bacterial Collection (miBC) provides host-specific insight into cultured diversity and functional potential of the gut microbiota , 2016, Nature Microbiology.

[28]  Paul J. McMurdie,et al.  DADA2: High resolution sample inference from Illumina amplicon data , 2016, Nature Methods.

[29]  Gregory B. Gloor,et al.  Compositional analysis: a valid approach to analyze microbiome high-throughput sequencing data. , 2016, Canadian journal of microbiology.

[30]  Corinne Rossi,et al.  Gut microbiome derived metabolites modulate intestinal epithelial cell damage and mitigate Graft-versus-Host Disease , 2016, Nature Immunology.

[31]  M. Hattori,et al.  Th17 Cell Induction by Adhesion of Microbes to Intestinal Epithelial Cells , 2015, Cell.

[32]  Wenjun Liu,et al.  Expanding the biotechnology potential of lactobacilli through comparative genomics of 213 strains and associated genera , 2015, Nature Communications.

[33]  Taosheng Chen,et al.  Efficacy of Retinoids in IKZF1-Mutated BCR-ABL1 Acute Lymphoblastic Leukemia. , 2015, Cancer cell.

[34]  Y. Taur,et al.  Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[35]  M. Robin,et al.  A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[36]  Daniel Wolff,et al.  Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[37]  G. Hill,et al.  Induced Regulatory T Cells Promote Tolerance When Stabilized by Rapamycin and IL-2 In Vivo , 2013, The Journal of Immunology.

[38]  M. Tomita,et al.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells , 2013, Nature.

[39]  A. Rudensky,et al.  Metabolites produced by commensal bacteria promote peripheral regulatory T cell generation , 2013, Nature.

[40]  Sean R. Eddy,et al.  Infernal 1.1: 100-fold faster RNA homology searches , 2013, Bioinform..

[41]  M. Hattori,et al.  Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota , 2013, Nature.

[42]  B. Zhu,et al.  Comparative analysis of the distribution of segmented filamentous bacteria in humans, mice and chickens , 2012, The ISME Journal.

[43]  Jeanne M. Marrazzo,et al.  Bacterial Communities in Women with Bacterial Vaginosis: High Resolution Phylogenetic Analyses Reveal Relationships of Microbiota to Clinical Criteria , 2012, PloS one.

[44]  R. Korngold,et al.  Induction of acute GVHD by sex-mismatched H-Y antigens in the absence of functional radiosensitive host hematopoietic-derived antigen-presenting cells. , 2012, Blood.

[45]  J. McNiff,et al.  Profound Depletion of Host Conventional Dendritic Cells, Plasmacytoid Dendritic Cells, and B Cells Does Not Prevent Graft-versus-Host Disease Induction , 2012, The Journal of Immunology.

[46]  B. Malissen,et al.  Recipient nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-host disease , 2011, Nature Medicine.

[47]  C. Huttenhower,et al.  Metagenomic biomarker discovery and explanation , 2011, Genome Biology.

[48]  E. Virginia Armbrust,et al.  pplacer: linear time maximum-likelihood and Bayesian phylogenetic placement of sequences onto a fixed reference tree , 2010, BMC Bioinformatics.

[49]  Dan R. Littman,et al.  Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria , 2009, Cell.

[50]  G. Wu,et al.  How to evaluate a gastric submucosal tumour in a patient with haematemesis? , 2005, Gut.

[51]  Daniel Metzger,et al.  Tissue‐specific and inducible Cre‐mediated recombination in the gut epithelium , 2004, Genesis.

[52]  K. Hashimoto,et al.  A conditional null allele of the major histocompatibility IA‐beta chain gene , 2002, Genesis.

[53]  O. Lantz,et al.  γ chain required for naïve CD4+ T cell survival but not for antigen proliferation , 2000, Nature Immunology.

[54]  M. Shlomchik,et al.  Prevention of graft versus host disease by inactivation of host antigen-presenting cells. , 1999, Science.

[55]  J. Crawford,et al.  An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. , 1996, Blood.

[56]  A. Imaoka,et al.  Segmented Filamentous Bacteria Are Indigenous Intestinal Bacteria That Activate Intraepithelial Lymphocytes and Induce MHC Class II Molecules and Fucosyl Asialo GM1 Glycolipids on the Small Intestinal Epithelial Cells in the Ex‐Germ‐Free Mouse , 1995, Microbiology and immunology.

[57]  MJ Grusby,et al.  Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice , 1991, Science.

[58]  R. Storb,et al.  Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. , 1979, The New England journal of medicine.

[59]  Brian H. McArdle,et al.  FITTING MULTIVARIATE MODELS TO COMMUNITY DATA: A COMMENT ON DISTANCE‐BASED REDUNDANCY ANALYSIS , 2001 .